Triasima Portfolio Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,715
Closed -$280K 145
2023
Q3
$280K Sell
2,715
-40
-1% -$4.31K 0.03% 119
2023
Q2
$421K Buy
+2,755
New +$313K 0.03% 120

Other funds holding MRK

Triasima Portfolio Management's MRK Position: Q4 2023 in Review

Triasima Portfolio Management sold out of Merck (MRK) in Q4 2023, closing a stake of 2,715 shares — an estimated $280K sold.

Triasima Portfolio Management first reported a position in MRK in Q2 2023 and held it in 2 quarters. The position peaked at $421K in Q2 2023. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Triasima Portfolio Management reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Triasima Portfolio Management sold 2,715 Merck shares in Q4 2023, an estimated $280K.
  • Triasima Portfolio Management first reported a position in Merck in Q2 2023 and held it in 2 quarters.
  • Triasima Portfolio Management's Merck position peaked at $421K in Q2 2023.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Triasima Portfolio Management's 13F filing for Q4 2023, filed 29 Jan 2024.